Human Drugs View

Product Information
Registration Number DRP-13800-03
Generic Name Co-Amoxiclav
Brand Name Retavacyl 125
Dosage Strength 156.25 mg/5mL
Dosage Form Powder for Oral Suspension
Classification Prescription Drug (Rx)
Pharmacologic Category Antibacterial (Penicillin+Beta-Lactamase Inhibitor)
Packaging 70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup / (Box of 1's)
Manufacturer Yeluri Formulations Pvt. Ltd
Country of Origin India
Trader
Importer Medinova Pharmaceutical Inc
Distributor Reta Drug
Application Type CLIDP Conversion
Issuance Date 25 July 2024
Expiry Date 22 November 2027